The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant.

Publication date: Jan 31, 2025

Open Access PDF

Concepts Keywords
Covid Activity
Improves Adapted
Infect Covid
Vaccine Dis
Improves
Infect
Kp
Lancet
Neutralising
Vaccine
Vaccines
Variant
Xec

Semantics

Type Source Name
drug DRUGBANK Coenzyme M
disease MESH infection
disease IDO assay
disease IDO blood
disease MESH Respiratory Diseases
disease MESH Infectious Diseases
disease IDO infectivity
disease MESH Allergy
disease MESH COVID 19

Original Article

(Visited 1 times, 1 visits today)